What is vv ecmo

Last updated: April 1, 2026

Quick Answer: VV ECMO (Veno-Venous Extracorporeal Membrane Oxygenation) is a life-support device that uses a pump and artificial lung to oxygenate blood outside the body, treating patients with severe respiratory failure who cannot breathe adequately on their own.

Key Facts

How VV ECMO Works

VV ECMO is an advanced life-support therapy that partially or fully takes over the function of the lungs. Blood is withdrawn from a large vein in the neck or groin, passed through an artificial membrane that oxygenates it while removing carbon dioxide, then returned to another vein. This veno-venous configuration allows the patient's heart to continue circulating blood, supporting severely compromised respiratory function.

Clinical Indications

VV ECMO is indicated for severe acute respiratory distress syndrome (ARDS), acute lung injury, and respiratory failure unresponsive to conventional mechanical ventilation. During the COVID-19 pandemic, VV ECMO became a critical intervention for patients with severe pneumonia and respiratory failure. The therapy provides time for lungs to recover or allows patients to reach a lung transplant evaluation and transplantation.

Medical Management

Managing VV ECMO patients requires intensive ICU care and specialized expertise. Anticoagulation is essential to prevent clot formation in the circuit, requiring careful monitoring of bleeding and clotting times. Complications can include bleeding, infection, hemolysis, and circuit thrombosis. Trained teams continuously monitor oxygenation, carbon dioxide removal, pump flow, and patient stability. Weaning protocols are gradual, testing the lung's recovery capability before discontinuation.

Outcomes and Prognosis

Survival rates for VV ECMO vary based on underlying cause and patient factors, ranging from 40-60% in experienced centers. The intensive nature and cost of ECMO therapy make it suitable only for appropriate candidates likely to benefit. Success depends on early identification of respiratory failure, rapid ECMO initiation, expert management, and favorable underlying lung pathology with recovery potential.

Related Questions

What is the difference between VV ECMO and VA ECMO?

VV ECMO uses two veins and supports lungs only, while VA ECMO uses an artery and vein and supports both heart and lungs. VA ECMO is used for cardiac failure; VV ECMO for isolated respiratory failure. VA ECMO carries higher risks of limb complications.

What is the difference between VV ECMO and VA ECMO?

VV ECMO provides respiratory support through venous drainage and return, while VA ECMO (veno-arterial) offers both respiratory and cardiac support by returning blood to an artery. VA ECMO is used for cardiac failure, whereas VV ECMO focuses on respiratory support.

How long can someone survive on VV ECMO?

VV ECMO can support patients for weeks to months depending on underlying condition and recovery. Most patients are weaned off within 2-4 weeks; some may require longer support while awaiting lung transplant or recovery.

How long can a patient stay on VV ECMO?

Patients typically remain on VV ECMO for days to several weeks depending on lung recovery. Some patients may be supported for extended periods, but extended support (>3-4 weeks) increases infection and complication risks.

What are the complications of VV ECMO?

Complications include bleeding and blood transfusion requirements, infection, mechanical circuit failure, clot formation, hemolysis (red blood cell destruction), and limb complications. Experienced centers manage these risks through careful monitoring and specialized protocols.

What is the success rate of VV ECMO treatment?

Success rates vary from 50-70% depending on the underlying condition and patient selection. Patients with ARDS from reversible causes like pneumonia tend to have better outcomes than those with severe sepsis.

Sources

  1. Wikipedia - Extracorporeal Membrane Oxygenation CC-BY-SA-4.0
  2. American Thoracic Society - ECMO Resources Fair Use